DiaMedica Therapeutics (DMAC) Non-Current Assets (2017 - 2026)
DiaMedica Therapeutics' Non-Current Assets was $686,000 in Q2 2026, up 75.4% from $391,000 a year earlier but down 4.3% from the prior quarter.
DiaMedica Therapeutics (DMAC) Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at DiaMedica Therapeutics came in at $742,000, down 57.2% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of 33.7% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $1.74 million in FY2024 (+257.7%), $485,000 in FY2023 (-13.4%), $560,000 in FY2022 (+400.0%) and $112,000 in FY2021 (-35.6%).
- Quarterly Non-Current Assets has moved between $85,000 (Q2 2022) and $20.82 million (Q2 2023) over five years.
- Compared with a year earlier, Non-Current Assets was higher in two of the last eight quarters, with an average decline of 1.0%.
- The best year-over-year quarter for Non-Current Assets over five years was Q1 2023 (growth of 443.0%); the worst was Q2 2024 (a decline of 91.5%).
- Per Business Quant data, DMAC's Non-Current Assets in the three quarters before Q2 2026 was $717,000 (Q1 2026), $742,000 (Q4 2025) and $824,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 14.88 Bn |
| 10 | DiaMedica Therapeutics | 445.97 Mn | 445.97 Mn | - | 686,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 686,000.00 |
| Mar 31, 2026 | 717,000.00 |
| Dec 31, 2025 | 742,000.00 |
| Sep 30, 2025 | 824,000.00 |
| Jun 30, 2025 | 391,000.00 |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 485,000.00 |
| Sep 30, 2023 | 10.25 Mn |
| Jun 30, 2023 | 20.82 Mn |
| Mar 31, 2023 | 543,000.00 |
| Dec 31, 2022 | 560,000.00 |
| Sep 30, 2022 | 551,000.00 |
| Jun 30, 2022 | 85,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 112,000.00 |
| Sep 30, 2021 | 127,000.00 |
DiaMedica Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=DMAC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "DMAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=DMAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();